04/26/2024 5:35 PM | KOZARICH JOHN W (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:47 PM | Davis Todd C (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 12:27 PM | Ligand Pharmaceuticals (Issuer) Sabba Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:28 PM | Aryeh Jason (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:12 PM | Ligand Pharmaceuticals (Subject) Sabba Stephen L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:49 PM | Davis Todd C (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/29/2024 5:50 PM | Korenberg Matthew E (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Ligand Pharmaceuticals (Issuer) Reardon Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:49 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Subject)
| Form 144/A | |
02/29/2024 3:16 PM | Ligand Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 5:05 PM | Gray Nancy Ryan (Reporting) Ligand Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 4:43 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 6:24 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 7:10 PM | Davis Todd C (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:10 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:10 PM | Korenberg Matthew E (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:10 PM | Ligand Pharmaceuticals (Issuer) Reardon Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:26 AM | Ligand Pharmaceuticals (Subject) MACQUARIE GROUP LTD (Filed by)
| Form SC 13G | |
02/13/2024 2:39 PM | JANUS HENDERSON GROUP PLC (Filed by) Ligand Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 6:42 PM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) Ligand Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024 1:03 PM | BlackRock Inc. (Filed by) Ligand Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/04/2024 3:07 PM | Korenberg Matthew E (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Ligand Pharmaceuticals (Issuer) Reardon Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 2:27 PM | Korenberg Matthew E (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 2:27 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 7:25 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 8:03 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 3:36 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2023 7:38 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 3:41 PM | Ligand Pharmaceuticals (Issuer) Zimmermann Martine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:12 PM | Ligand Pharmaceuticals (Issuer) Zimmermann Martine (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/25/2023 3:44 PM | Davis Todd C (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 4:26 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 3:20 PM | Ligand Pharmaceuticals (Issuer) Reardon Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 5:42 PM | Espinoza Octavio (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 5:42 PM | Korenberg Matthew E (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 8:28 AM | Ligand Pharmaceuticals (Issuer) Sabba Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:52 PM | Davis Todd C (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:53 PM | Haas Jason (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:54 PM | Aryeh Jason (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
He Is Giving Away Bitcoin (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
06/13/2023 5:54 PM | KOZARICH JOHN W (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:55 PM | LAMATTINA JOHN L (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:55 PM | Gray Nancy Ryan (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 4:18 PM | KOZARICH JOHN W (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 2:43 PM | Ligand Pharmaceuticals (Issuer) Sabba Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2023 6:07 PM | Ligand Pharmaceuticals (Subject) Sabba Stephen L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023 6:15 PM | KOZARICH JOHN W (Reporting) Ligand Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 3:06 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |